WuXi Biologics Passes FDA GMP Inspection at Wuxi Site
Wuxi, China, September 24, 2026 WuXi Biologics has announced that its drug substance and drug product manufacturing facilities at...
artificial intelligence
Advertisement
Clywedog Therapeutics Reports Phase 1b Balomenib Results
Durham, North Carolina, U.S., September 24, 2026 Clywedog Therapeutics has announced final results from its Phase 1b clinical study...
Veeva Systems Launches AI Agent for Clinical Study Builds
Pleasanton, California, U.S., September 24, 2026 Veeva Systems Inc. has announced the Veeva Study Builder Agent, a new artificial...
Theranica Reports 91% Precision in AI Migraine Forecasting Study
BRIDGEWATER, N.J. and CAESAREA, Israel — September 23, 2026 Theranica announced peer-reviewed results from a study evaluating its Your...
Oracle Expands Life Sciences Data Intelligence With AI and RWD
ORLANDO, Fla. — September 23, 2026 Oracle announced expanded capabilities in Oracle Life Sciences Data Intelligence, combining real-world data,...
Advertisements
Seek Labs Launches Open Impact Program for Neglected Diseases
SALT LAKE CITY, Utah — September 22, 2026 SALT LAKE CITY, Utah — September 22, 2026 — Seek Labs...
KELLS Gains Singapore HSA Registration for AI Dental Scan
Singapore and New York, September 16, 2026 KELLS, Inc. has announced that its KELLS AI Dental Scan has been...
Roche Opens Boston Innovation Center for CVRM Research
BASEL, Switzerland — September 17, 2026 Roche announced the grand opening of the Roche Genentech Innovation Center Boston, expanding...
Avenda Health Brings AI Prostate Cancer Mapping to Arizona
Irvine, California, U.S., September 18, 2026 Avenda Health, an artificial intelligence-powered medical technology company focused on prostate cancer care,...
Accro Bioscience Advances Rare Disease Drug Development
Shanghai, China, September 11, 2026 Accro Bioscience has announced that its investigational AC-101 tablets have been included in the...
Advertisement
